AtaiBeckley Inc.

AtaiBeckley is a drug development company working on treatments for mental health conditions like depression, anxiety, and schizophrenia. The company is testing several experimental medications in clinical trials, including some based on psychedelic compounds like psilocybin and DMT. Most of these drugs are still in early testing stages and have not been approved by regulators yet. The company was founded in 2018 and operates in the United States, Germany, and Canada.